Principal Scientist, In Vivo Pharmacology, Translational Oncology
Genentech | |
United States, California, South San Francisco | |
Feb 11, 2026 | |
|
The Position
The Opportunity Join our mission to transform the lives of cancer patients by discovering and developing next-generation therapeutics. We are seeking an accomplished and highly motivated scientific leader to join our In Vivo Pharmacology/Translational Oncology team within the Research Oncology department. In this role, you will lead a dedicated team of scientists responsible for driving our diverse oncology pipeline, from early discovery to clinical translation. You will provide the scientific and strategic leadership needed to evaluate novel therapeutic concepts, establish clear translational hypotheses, and deliver the critical data packages that advance our most promising drug candidates into the clinic. This is a highly visible and impactful position for a leader who thrives in a collaborative, science-driven environment. Key Responsibilities
Who You Are
Relocation benefits are available for this posting. The expected salary range for this position based on the primary location of California is $143,200 to $265,900. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors permitted by law. A discretionary annual bonus may be available based on individual and Company performance. This position also qualifies for the benefits detailed at the link provided below. Benefits #LI-KC2 Genentech is an equal opportunity employer. It is our policy and practice to employ, promote, and otherwise treat any and all employees and applicants on the basis of merit, qualifications, and competence. The company's policy prohibits unlawful discrimination, including but not limited to, discrimination on the basis of Protected Veteran status, individuals with disabilities status, and consistent with all federal, state, or local laws. If you have a disability and need an accommodation in relation to the online application process, please contact us by completing this form Accommodations for Applicants. | |
Feb 11, 2026